Literature DB >> 9071928

The relationship between acid and bile reflux and symptoms in gastro-oesophageal reflux disease.

R E Marshall1, A Anggiansah, W A Owen, W J Owen.   

Abstract

BACKGROUND: The role of bile in the genesis of oesophageal symptoms and disease is incompletely understood. A new method of ambulatory bile monitoring may help to define this role. AIMS: To establish the relationship between symptom events and acid and bile reflux episodes. PATIENTS: 59 consecutive patients presenting for further investigation of gastro-oesophageal reflux disease.
METHODS: All patients underwent combined ambulatory pH and bile monitoring. For each patient, a symptom index (SI) was calculated in relation to both acid reflux and bile reflux episodes.
RESULTS: Patients were divided into those without (group 1, n = 21) and those with (group 2, n = 38) acid reflux. A total of 394 symptoms were identified in 59 patients. In group 1, there were fewer symptom events per patient (mean 4.1) than group 2 (mean 8.1). Twenty three per cent of symptom events were associated with acid reflux in group 1 and 41% in group 2. Only 6% of symptom events in both groups were related to bile reflux. In group 1 both the acid and bile related SI score were low. In group 2 the bile related SI score was low, but the acid related SI score was high.
CONCLUSIONS: Symptoms are much more often related to acid reflux than bile reflux. Bile reflux does not seem to be a major factor in producing oesophageal symptoms.

Entities:  

Mesh:

Year:  1997        PMID: 9071928      PMCID: PMC1027045          DOI: 10.1136/gut.40.2.182

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  Ambulatory oesophageal bile reflux monitoring in Barrett's oesophagus.

Authors:  R E Marshall; A Anggiansah
Journal:  Br J Surg       Date:  1996-03       Impact factor: 6.939

2.  The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring.

Authors:  G J Wiener; J E Richter; J B Copper; W C Wu; D O Castell
Journal:  Am J Gastroenterol       Date:  1988-04       Impact factor: 10.864

3.  Characteristics of distal partial gastrectomy patients with esophageal symptoms of duodenogastric reflux.

Authors:  R J Sears; G L Champion; J E Richter
Journal:  Am J Gastroenterol       Date:  1995-02       Impact factor: 10.864

4.  Do bile acids reflux into the esophagus? A study in normal subjects and patients with gastroesophageal reflux disease.

Authors:  R K Mittal; A Reuben; J O Whitney; R W McCallum
Journal:  Gastroenterology       Date:  1987-02       Impact factor: 22.682

5.  Regnerative of cardiac type mucosa and acquisition of Barrett mucosa after esophagogastrostomy.

Authors:  S R Hamilton; J H Yardley
Journal:  Gastroenterology       Date:  1977-04       Impact factor: 22.682

6.  Bile salts in the esophagus of patients with esophagitis.

Authors:  F Johnsson; B Joelsson; C H Florén; A Nilsson
Journal:  Scand J Gastroenterol       Date:  1988-08       Impact factor: 2.423

7.  Intragastric bile acids and scintigraphy in the assessment of duodenogastric reflux.

Authors:  P W Houghton; N J Mortensen; W E Thomas; M J Cooper; A P Morgan; E R Davies
Journal:  Br J Surg       Date:  1986-04       Impact factor: 6.939

Review 8.  Duodenogastric reflux and foregut carcinogenesis.

Authors:  K Miwa; T Hattori; I Miyazaki
Journal:  Cancer       Date:  1995-03-15       Impact factor: 6.860

9.  Alkaline gastro-oesophageal reflux: dual probe pH monitoring.

Authors:  S Y Iftikhar; S Ledingham; D F Evans; S W Yusuf; R J Steele; M Atkinson; J D Hardcastle
Journal:  Gut       Date:  1995-10       Impact factor: 23.059

10.  The symptom sensitivity index: a valuable additional parameter in 24-hour esophageal pH recording.

Authors:  R Breumelhof; A J Smout
Journal:  Am J Gastroenterol       Date:  1991-02       Impact factor: 10.864

View more
  13 in total

1.  Reconstructive procedure after distal gastrectomy for gastric cancer that best prevents duodenogastroesophageal reflux.

Authors:  Kenichiro Fukuhara; Harushi Osugi; Nobuyasu Takada; Masashi Takemura; Masayuki Higashino; Hiroaki Kinoshita
Journal:  World J Surg       Date:  2002-10-10       Impact factor: 3.352

2.  Dietary restrictions during ambulatory monitoring of duodenogastroesophageal reflux.

Authors:  Jan Tack; Raf Bisschops; Gerardus Koek; Daniel Sifrim; Tony Lerut; Jozef Janssens
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

Review 3.  Symptom association analysis in ambulatory gastro-oesophageal reflux monitoring.

Authors:  A J Bredenoord; B L A M Weusten; A J P M Smout
Journal:  Gut       Date:  2005-12       Impact factor: 23.059

4.  Analysis of ambulatory duodenogastroesophageal reflux monitoring.

Authors:  R Cuomo; G Koek; D Sifrim; J Janssens; J Tack
Journal:  Dig Dis Sci       Date:  2000-12       Impact factor: 3.199

5.  Oesophageal clearance of acid and bile: a combined radionuclide, pH, and Bilitec study.

Authors:  G H Koek; R Vos; P Flamen; D Sifrim; F Lammert; B Vanbilloen; J Janssens; J Tack
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

6.  [Antireflux therapy--more than acid reduction?].

Authors:  T Frieling
Journal:  Internist (Berl)       Date:  2004-12       Impact factor: 0.743

7.  Duodenogastric Reflux-induced (Alkaline) Esophagitis.

Authors:  Joel E. Richter
Journal:  Curr Treat Options Gastroenterol       Date:  2004-02

Review 8.  Diagnostic options for patients with refractory GERD.

Authors:  Fernando Fornari; Daniel Sifrim
Journal:  Curr Gastroenterol Rep       Date:  2008-06

Review 9.  Molecular pathways and genetic factors in the pathogenesis of laryngopharyngeal reflux.

Authors:  Alexios S Vardouniotis; Alexander D Karatzanis; Eleni Tzortzaki; Elias Athanasakis; Katerina D Samara; Georgios Chalkiadakis; Nikolaos Siafakas; George A Velegrakis
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-04-02       Impact factor: 2.503

10.  Functional Heartburn.

Authors:  Jan Tack; Jozef Janssens
Journal:  Curr Treat Options Gastroenterol       Date:  2002-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.